featured
Autologous Transplant vs CAR T-Cell Therapy in Patients With DLBCL in Complete Remission
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Cancer Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission
Blood Cancer J 2024 Jul 08;14(1)108, M Shadman, KW Ahn, M Kaur, L Lekakis, A Beitinjaneh, M Iqbal, N Ahmed, B Hill, NM Hossain, P Riedell, AK Gopal, N Grover, M Frigault, J Brammer, N Ghosh, R Merryman, A Lazaryan, R Ram, M Hertzberg, B Savani, F Awan, F Khimani, S Ahmed, VP Kenkre, M Ulrickson, N Shah, MA Kharfan-Dabaja, A Herrera, C Sauter, M HamadaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.